The information below is presented by ThePigSite.com on behalf of Boehringer Ingelheim.
If you wish to contact Boehringer Ingelheim you can do so by visiting their contact page |
ENTERISOL® ILEITIS
Enterisol® Ileitis:
the first and only vaccine for the control of Porcine Proliferative Enteropathy.
Latest Enterisol Ileitis News and Features
Benefits of Enterisol Ileitis
Click here to download our comprehensive product data sheet.
Enterisol® Ileitis approved in Australia - first live swine vaccine ever in this market AUSTRALIA - Boehringer Ingelheim Animal Health GmbH, announced today that the Australian regulatory authorities have granted market authorization for the porcine live vaccine Enterisol® Ileitis. Enterisol®... Economic Impact of Enterisol® Ileitis in Clinical and Subclinical Herds By M. Adam, Boehringer Ingelheim Animal Health GmbH, Ingelheim, Germany. Worldwide, ileitis is prevalent in 3 forms: acute, chronic and subclinical.... Field Experiment with Enterisol® Ileitis in Spain By José Luis Lorenzo and Mª Luisa Rosas of MAPORC S.C. Segovia. Ileitis is a very common disease, and its prevalence is very high on most farms in Spain.... North American PRRS Symposium: 25 years of lessons learned Dr. Mike Roof, executive director of swine R&D with Boehringer Ingelheim, delivered the keynote address to attendees of the North American PRRS Symposium on Sunday in Chicago, addressing 25 years of PRRS... “At The Meeting” goes in-depth on African Swine Fever in new episode The ongoing discussion about African Swine Fever (ASF) outbreaks in China and Europe has many in the swine industry on edge. ... New “At The Meeting” episodes discuss summer PRRS outbreaks and latest research on PCV3 In two new episodes of the “At The Meeting … Honoring Dr Bob Morrison” podcast, cohosts Dr Tom Wetzell, Dr Gordon Spronk and Dr Montserrat Torremorell visit with researchers about possible factors... New software streamlines custom-vaccine management for livestock veterinarians Newport Laboratories, Inc., a leader in livestock custom-made vaccines (CMVs), today launches HerdPoint,™ a new solution for veterinarians that streamlines the nonadjacent-herd approval process and ongoing... |
|
Boehringer Ingelheim Animal Health GmbH, 55216 Ingelheim, Germany. www.boehringer-ingelheim.com |